Abstract
Introduction
Epilepsy is one of the most common serious neurological disorders that affect approximately 65 million people worldwide [1] . People with epilepsy are at an increased risk of death, which is between 1.6 and 4.1 fold greater than that of the general population. Most current treatments are symptomatic therapies that suppress seizures without preventing the initial development or progression of epilepsy [2] . Although over twenty anti-seizure medications exist and are effective in some cases, more than one-third of patients with epilepsy are intractable to all medications [3] .
The Homer family proteins are divided into the short form, Homer1a, and long forms that include Homer1b/c, Homer2 and Homer3 [4] . These recently discovered postsynaptic scaffolding proteins function as molecular adaptors that play a central role in Ca 2+ signaling. They share a conserved N-terminal Ena/VASP homology 1 (EVH1) domain which acts as a protein-protein interaction motif to bind a proline-rich consensus sequence (PPXXFR) in various other scaffolding and signal transduction molecules, including metabotropic glutamate receptors (mGluRs) and 1,4,5-trisphosphate receptors (IP 3 Rs), and assembles these signaling proteins into complexes [5] . Within Homer1 proteins, Homer1b/c can selfmultimerize through a C-terminal coiled-coil (CC) domain and function as scaffolds of multiprotein complexes and mediators of group I mGluRs signaling. In contrast, Homer1a, which lacks the dimerization domain, can competitively bind to Homer1b/c-targeted proteins and behave as a dominant negative [6] . Substantial preclinical investigations have implicated that each of these Homer 1 variants are associated with the etiology of many neurological diseases, such as chronic pain, mental retardation syndromes, Alzheimer's disease (AD), Parkinson's disease (PD), schizophrenia, drug-induced addiction, and traumatic brain injury (TBI) [7, 8] . More recently, downregulation of Homer1b/c was shown to inhibit glutamate induced excitotoxicity and protect against traumatic neuronal injury in cortical neurons [9, 10] . However, no study to date has investigated the role of Homer1b/c in epileptic seizures.
In the present study, we tested directly the effects of reducing Homer1b/c expression on baseline behavior and chemically induced seizure severity. We also investigated the potential underlying molecular mechanism with focus on mGluR5 activity and the mammalian target of rapamycin (mTOR) pathway.
Materials and Methods
Cell culture PC12 cells were purchased from the Institute of Biochemistry and Cell Biology, SIBS, CAS. The cells were grown in Dulbecco's modified Eagle's medium (DMEM, Gibicon) plus 10% foetal bovine serum (Hyclone Laboratories, Logan, UT) and 1% antibiotics (penicillin/streptomycin, Sigma) in a humidified atmosphere of 95% air and 5% CO 2 at 37°C. The medium was changed every 2-3 days.
RNA interference transfection
Double-stranded small interfering RNA (siRNA) transfection was used to down-regulate Homer1b/c expression in vitro. All siRNAs were purchased from Santa Cruz Biotech (Santa Cruz, CA, USA). PC12 cells were transfected with Si-H1b/c (Homer1b/c siRNA) using Lipofectamine RNAiMAX transfection Immunofluorescence reagent according to the manufacturer's protocol (Invitrogen, Carlsbad, CA, USA). A control siRNA (Si-con), which has no homology to any known sequence, was used in parallel experiments. For in vivo knockdown, 50 μg Si-H1b/c or Si-con was infused into hippocampus by using a stereotaxic injection (Fig. 1) . The mRNA and protein expression levels were measured 72 h after transfection.
Real-time RT-PCR
Total RNA was isolated using Trizol reagent (Invitrogen). After the equalization of the RNA quantity in each group, the mRNA levels were quantitated using a Bio-Rad iQ5 Gradient Real-Time PCR system (Bio-Rad Laboratories), and GAPDH was used as an endogenous control. Primers for all Real-Time PCR experiments were listed as follow: Homer1a: forward: 5'-GTGTCCACAGAAGCCAGAGAGGG-3', reverse: 5'-AATGAAGGGGTCATTGATGG-3'. Samples were tested in triplicates and data from five independent experiments were used for analysis.
Sensorimotor battery and 1 h locomotor activity
All mice were evaluated on a battery of sensorimotor tests designed to assess balance, strength, coordination and initiation of movement as described previously [11] . Locomotor activity was evaluated in all mice over a 1 h period using computerized photobeam instrumentation. General activity variables and indices of emotionality, including time spent, distance traveled, and entries made in a 33 × 11 cm central zone, were analyzed.
Morris water maze
Spatial learning and memory were evaluated in the Morris water maze as described previously [12] . The protocol included cued, place, and probe trials and all trials were performed in a 120-cm-diameter pool filled with opaque water. Escape path length, latency, and swimming speeds were calculated for the cued and place trials. Spatial bias for the target quadrant was analyzed by comparing the time spent in it versus the times spent in each of the other quadrants.
Elevated plus maze
As described previously [11] , the elevated plus maze (EPM) apparatus is a four-arm maze shaped like a plus sign. One set of the opposing arms have walls (closed arms) and the other set is not enclosed (open arms). The number of entries made, time spent, and distance traveled in each set of arms were quantified. These three variables were also analyzed after normalizing the values to reflect percentages calculated out of the totals measured in both sets of arms.
Picrotoxin and pentylenetetrazole seizures
In vivo picrotoxin (PTX, Invitrogen) reverse microdialysis experiments from awake and freely moving mice were developed with modifications to the previously described method [11] . Pentylenetetrazole (PTZ, Invitrogen) was dissolved in sterile PBS at a concentration of 5 mg/ml. A dose of 80 mg/kg was delivered intraperitoneally for the experiments shown in Fig. 3C-3E . Each mouse was videotaped for 15 min to score seizure severity.
EEG recording and seizure severity scores A previously published protocol was used to record EEG activity [11] . EEG spike frequency was assessed for the last 60 min and normalized to basal EEG of each mouse. The seizure severity score used was as follows: 0 = normal behavior; 1 = immobility; 2 = spasm, tremble, or twitch; 3 = tail extension; 4 = forelimb clonus; 5 = generalized clonic activity; 6 = jumping or running seizures; 7 = full tonic extension; and 8 = death. 
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Western blot analysis Equivalent amounts of protein (40 μg per lane) were loaded and separated by 10% SDS-PAGE gels, and transferred to polyvinylidene difluoride (PVDF) membranes. Membranes were blocked with 5% nonfat milk solution in tris-buffered saline with 0.1% Triton X-100 (TBST, Sigma) for 1 h, and then incubated overnight at 4°C with the primary Homer1a antibody (1:200, Santa Cruz), Homer1b/c (1:800, Santa Cruz), p-mTOR (1:500, Cell Signaling), mTOR (1:1000, Cell Signaling), p-S6 (1:500, Cell Signaling), S6 (1:1000, Cell signaling), mGluR5 (1:800, Abcom) or β-actin (1:600, Cell Signaling) antibody dilutions in TBST. After that the membranes were washed and incubated with secondary antibody for 1 h at room temperature. Immunoreactivity was detected with Super Signal West Pico Chemiluminescent Substrate (Thermo Scientific, Rockford, IL, USA). An analysis software named Image J (Scion Corporation) was used to quantify the optical density of each band.
Statistical analysis
Statistical analysis was performed using SPSS 16.0, a statistical software package. Statistical evaluation of the data was performed by one-way analysis of variance (ANOVA) followed by Bonferroni's multiple comparisons. A value of p < 0.05 was considered statistically significant.
Results

Down-regulation of Homer1b/c expression in vivo
To determine the functional effects of reducing Homer1b/c mRNA and protein in vivo, Homer1b/c specific targeted siRNA (Si-H1b/c) and a control siRNA (Si-con), which should not knock down any known proteins, were used in the following experiments. After confirming its ability to reduce Homer1b/c expression in murine PC12 cells ( Fig. 2A) , we infused 50 μg of Si-H1b/c into the hippocampus of adult mice using saline and Si-con as controls (Fig. 1) . Three days after infusion, the hippocampus surrounding the injection site was analyzed for 
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Homer1b/c expression using RT-PCR (Fig. 2B ) and western blot ( Fig. 2C and 2D ). Si-H1b/c infused in the hippocampus provided >70% reduction of Homer1b/c mRNA and protein, but had no effects on Homer1a expression. In addition, the results showed that the Homer1b/c mRNA levels remained >70% decreased at 9 days and >50% decreased at 12 days after SiH1b/c infusion, indicating a long-term target knockdown of Homer1b/c in vivo.
Knockdown of Homer1b/c does not alter baseline behavior
Before assessing whether Homer1b/c knockdown can provide protection against seizures, we first analyzed the mice for any gross motor or cognitive abnormalities. Mice with decreased Homer1b/c levels performed similarly to bothsaline and Si-con groups in the inverted screen test (Fig. 3A) . The Si-H1b/c infused mice did not exhibit any significant performance deficits on the place (Fig. 3B) or probe (Fig. 3C ) trials in the water maze, suggesting that their spatial learning and memory were intact. Analysis of the EPM data also showed that the Si-H1b/c infused mice did not differ in levels of anxiety-related behaviors compared with the saline and Si-con groups, as evidenced by the results of percentage of open arm entries (Fig. 3D) , percentage of open arm time (Fig. 3E) and percentage of open arm distance (Fig. 3F) .
Reducing Homer1b/c expression protects against chemically induced seizure
The PTX induced seizure model was used to determine whether Homer1b/c reduction is protective against focal seizure, and the results showed that the Si-H1b/c infused mice showed a reduction in normalized spike frequency compared with the saline and Si-con groups (Fig. 4A) . The total Homer1b/c protein levels in the left hippocampus of mice were highly correlated with normalized spike frequency (Fig. 4B) , indicating a direct correction between lower Homer1b/c protein levels and reduced neuronal hyperexcitability. In addition, we also tested the effects of Homer1b/c reduction in a widely used seizure paradigm: 
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Cellular Physiology and Biochemistry adult mouse, no significant deviations from baseline were observed in a battery of motor and learning/memory behavior tasks, indicating that short-term Homer1b/c downregulation is well tolerated in vivo. In the setting of chemically induced seizures, Homer1b/c reduction protected against seizure severity, and a significant correlation between total Homer1b/c protein levels in the brain and seizure severity both in Si-H1b/c treated mice and in Sicon treated mice was observed. These data strengthen the link between total Homer1b/c expression levels and neuronal hyperexcitability regulation in vivo and demonstrate that the Homer1b/c reduction effect on neuronal hyperexcitability is likely a Homer1b/c mediated event and not a developmental phenomenon. The involvement of Homer proteins in a number of neuropathological conditions, such as chronic inflammatory pain, drug addiction, major depression and sleep loss, has been investigated in recent years [7, 13, 14] . In this study, we provide the first direct evidence that Homer1b/c, a constitutively expressed long form of Homer proteins, plays an important role in chemically induced seizure models. Reducing Homer1b/c expression has been shown in previous studies to be protective against excitotoxic insults [10] , implicating Homer1b/c in the physiological regulation of aberrant neuronal excitability. In addition, antagonizing Homer1b/c function through Homer1a overexpression was shown to attenuate neuronal injury in both in vitro and in vivo TBI models [15] . These reports, in conjunction with previous data using Homer1b/c targeted siRNA to protect neurons form traumatic injury [9] and our own in vivo Homer1b/c knockdown data in two different seizure models, support the application of a Homer1b/c lowering therapy to regulate hyperexcitability. PTX and PTZ kindling are the most widely-accepted animal models used to study seizure mechanisms and to discover novel treatments for seizures [16, 17] . Given that the compounds that provide protection against PTZ seizures in vivo have generally been successful in subsequent human clinical trials [18] , our findings of Homer1b/c knockdown using two different GABA antagonists will also apply broadly to epilepsy in vivo models and to human epilepsy.
The mTOR is a serine/threonine kinase that normally regulates a number of cellular functions, such as cell growth, proliferation, metabolism, protein synthesis, neuronal development and synaptic plasticity, many of which could affect neuronal excitability and epileptogenesis [19] . Dysregulation of mTOR pathway has been demonstrated in a variety of genetic and acquired epilepsies, and mTOR inhibitors was shown to prevent the development of seizures and associated cellular and molecular abnormalities that promote epileptogenesis in these models, such as glial proliferation, neuronal hypertrophy, and deficient glutamate transporters [20, 21] . In the present study, protection of Homer1b/c knockdown against seizures in two chemically induced models was accompanied by decreased phosphorylation of mTOR and its downstream target protein S6. This result confirms the involvement of mTOR pathway, however, it remains to be elucidated whether, in these animal models, mTOR is inactivated as a consequence of seizures or is involved in the epileptogenic process and/ or seizure generation. Among numerous upstream signaling pathways that may regulate mTOR, the mGluRs pathway represents a logical candidate for mediating the effects of seizures, because seizures result in massive glutamate release and glutamate can stimulate several glutamate receptors [22] . Of the mGluRs family, group I mGluRs (type 1 and type 5) have gained the most attention and mGluR5 may participate in the events underlying long-term depression (LTD), a form of synaptic plasticity that likely contributes to learning and memory [23] . Moreover, activation of mGluR5 was shown to regulate intracellular Ca 2+ influx and endoplasmic reticulum (ER) Ca 2+ release through a Homer1b/c-dependent mechanism [10, 24, 25] . Our data showed that Homer1b/c knockdown-induced inhibition of mTOR pathway was partially ablated by mGluR5 agonist CHPG, with no effects on mGluR5 expression, indicating that the protection observed in our study might be associated with the inhibition of mGluR5-mTOR pathway, which might be demonstrate on mGluR5 knockout mice in further studies.
Although we clearly demonstrated the protective effects of Homer1b/c reduction against chemically induced seizures, these findings have some limitations. First, the reduction of Homer1b/c was induced by infusion of Si-H1b/c into the hippocampus, and this strategy had minor effects on the expression of Homer1b/c in other brain regions, such as striatum corpora and cerebral ganglion, which are also involved in the initial development or progression of epilepsy [26] . Some experiments using Homer1b/c knock-out mice might be helpful to confirm our findings. Second, Homer1a mRNA levels were shown to be upregulated in the acute period of the pilocarpine epilepsy model [27] . Although our data showed that the expression of Homer1a mRNA and protein was not altered by Si-H1b/c infusion, the induction of Homer1a mRNA after seizure might interfere activity of Homer1b/c and downstream signaling cascades in our models. Further studies should be done to determine the exact role of each of these Homer 1 variants under epileptic seizure conditions.
Conclusions
In conclusion, we have confirmed and extended the knowledge that knockdown of Homer1b/c, by inhibiting the mGluR5-mediated activation of mTOR pathway, has antiantiepileptogenic (anti-seizure) properties. We have demonstrated for the first time that reducing Homer1b/c expression protect against chemically induced seizure without effects on baseline behavior. Therefore, the Homer1b/c reduction strategy outlined here may have potential to be translated to the clinical setting for patients with epilepsy.
